{"id":411882,"date":"2021-01-11T08:03:25","date_gmt":"2021-01-11T13:03:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=411882"},"modified":"2021-01-11T08:03:25","modified_gmt":"2021-01-11T13:03:25","slug":"portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/","title":{"rendered":"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors"},"content":{"rendered":"
\n

\n Click <\/em>
\n
\n
\n here<\/u>
\n <\/em>
\n <\/a>
\n to join the case<\/em>
\n \n <\/p>\n

\n LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) — <\/strong>\n <\/p>\n

\n
\n The Portnoy Law Firm<\/u>
\n <\/a> advises investors that a class action lawsuit has been filed on behalf of Biogen, Inc. (“Biogen” or “the Company”) (NASDAQ: BIIB) investors that acquired securities between October 22, 2019 to November 6, 2020.<\/p>\n

Investors are encouraged to contact attorney Lesley F. Portnoy<\/u><\/a>, to determine eligibility to participate in this action, by phone 310-692-8883 or email<\/u><\/a>, or click here<\/u><\/a> to join the case.<\/p>\n

It is alleged within the complaint that Biogen made misleading and false statements to the public throughout the Class Period and failed to disclose material adverse facts about Biogen\u2019s business, operational, and compliance policies. Specifically, Biogen made misleading and\/or false statements concerning: (1) Study 302, viewed independently, did not provide convincing evidence in support of the effectiveness of aducanumab; (2) Study 103 did not provide convincing evidence of the effectiveness of aducanumab; (3) Study 302 could not be considered as primary evidence of aducanumab\u2019s effectiveness for the treatment of Alzheimer\u2019s disease in light of the results of the exploratory analyses of Study 301 and 302, and the results of Study 103; (4) the totality of the data did not provide sufficient evidence to support aducanumab\u2019s efficacy for the treatment of Alzheimer\u2019s disease; and (5) Biogen\u2019s statements about its business, operations, and prospects, were materially false and misleading and\/or lacked a reasonable basis at all relevant times as a result.<\/p>\n

Please visit our website<\/u><\/a> to review more information and submit your transaction information.<\/p>\n

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm\u2019s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.<\/p>\n

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com<\/u><\/a>
310-692-8883
www.portnoylaw.com<\/p>\n

Attorney Advertising<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Click here to join the case LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Biogen, Inc. (“Biogen” or “the Company”) (NASDAQ: BIIB) investors that acquired securities between October 22, 2019 to November 6, 2020. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged within the complaint that Biogen made misleading and false statements to the public throughout the Class Period and failed to disclose material adverse facts about Biogen\u2019s business, operational, and compliance policies. Specifically, Biogen made misleading and\/or false … <\/p>\n

Continue reading “Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-411882","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nPortnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Click here to join the case LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Biogen, Inc. (“Biogen” or “the Company”) (NASDAQ: BIIB) investors that acquired securities between October 22, 2019 to November 6, 2020. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged within the complaint that Biogen made misleading and false statements to the public throughout the Class Period and failed to disclose material adverse facts about Biogen\u2019s business, operational, and compliance policies. Specifically, Biogen made misleading and\/or false … Continue reading "Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-11T13:03:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors\",\"datePublished\":\"2021-01-11T13:03:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/\"},\"wordCount\":307,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/\",\"name\":\"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=\",\"datePublished\":\"2021-01-11T13:03:25+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/","og_locale":"en_US","og_type":"article","og_title":"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors - Market Newsdesk","og_description":"Click here to join the case LOS ANGELES, Jan. 11, 2021 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Biogen, Inc. (“Biogen” or “the Company”) (NASDAQ: BIIB) investors that acquired securities between October 22, 2019 to November 6, 2020. Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case. It is alleged within the complaint that Biogen made misleading and false statements to the public throughout the Class Period and failed to disclose material adverse facts about Biogen\u2019s business, operational, and compliance policies. Specifically, Biogen made misleading and\/or false … Continue reading \"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/","og_site_name":"Market Newsdesk","article_published_time":"2021-01-11T13:03:25+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors","datePublished":"2021-01-11T13:03:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/"},"wordCount":307,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/","name":"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=","datePublished":"2021-01-11T13:03:25+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODEyMzEwOSMzOTExMzYyIzIxOTU1Mjc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/portnoy-law-lawsuit-filed-on-behalf-of-biogen-inc-investors\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Portnoy Law: Lawsuit Filed On Behalf of Biogen, Inc. Investors"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=411882"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/411882\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=411882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=411882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=411882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}